Innovator MSCI Competition

Etfs . USA . 
Etf . Innovator MSCI EAFE
IJAN Etf  USD 31.08  0.15  0.48%   
Innovator MSCI EAFE competes with ABIVAX Société, Pinnacle Sherman, Morningstar Unconstrained, SPACE, and Malaga Financial; as well as few others. Analyzing Innovator MSCI competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Innovator MSCI to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Innovator MSCI Correlation with its peers.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Innovator MSCI competition on your existing holdings.
  
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
30.4931.0831.67
Details
Intrinsic
Valuation
LowRealHigh
30.7231.3131.90
Details
Naive
Forecast
LowNextHigh
30.4331.0231.61
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
30.6431.0731.51
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Innovator MSCI. Your research has to be compared to or analyzed against Innovator MSCI's peers to derive any actionable benefits. When done correctly, Innovator MSCI's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Innovator MSCI EAFE.

Innovator MSCI Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Innovator MSCI and its competitors represents the degree of relationship between the price movements of corresponding etfs. A correlation of about +1.0 implies that the price of Innovator and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Innovator MSCI EAFE does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
GSHD
+ 0.98
SEIC
SEIC
+ 0.93
IPSHX
GSHD
+ 0.9
IPSHX
KNF
+ 0.87
IPSHX
ID
+ 0.86
IPSHX
SEIC
+ 0.86
KNF
  
High negative correlations   
GSHD
- 0.13
CIRAX
SEIC
- 0.05
CIRAX
GSHD
- 0.0
AAVXF
SEIC
- 0.0
AAVXF
CIRAX
- 0.0
AAVXF
LICY
- 0.0
AAVXF

Innovator MSCI Constituents Risk-Adjusted Indicators

There is a big difference between Innovator Etf performing well and Innovator MSCI ETF doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Innovator MSCI's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
AAVXF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
IPSHX  0.55  0.03  0.02  0.15  0.45 
(0.68)
 1.13 
(0.98)
 3.97 
MSTSX  0.49 (0.04)(0.13) 0.06  0.52 
(0.61)
 1.21 
(1.02)
 2.80 
ID  3.77  0.53  0.10  0.68  4.01 
(5.10)
 7.69 
(6.67)
 20.54 
MLGF  0.37  0.02 (0.14) 0.33  0.34 
(0.73)
 1.11 
(0.65)
 3.32 
KNF  1.55  0.21  0.13  0.23  1.90 
(1.62)
 2.77 
(2.46)
 12.78 
LICY  6.73  0.67  0.09  0.90  6.69 
(8.44)
 14.15 
(10.47)
 55.51 
CIRAX  0.34 (0.05)(0.26) 0.00  0.43 
(0.34)
 0.66 
(0.82)
 1.81 
SEIC  0.81  0.21  0.19  0.37  0.57 
(0.95)
 1.57 
(1.56)
 7.23 
GSHD  1.67  0.61  0.41  1.00  0.83 
(2.15)
 5.06 
(2.22)
 14.35 
All Fundamental Data

Innovator MSCI Competitive Analysis

The better you understand Innovator MSCI competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Innovator MSCI's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Innovator MSCI's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
IJAN AAVXF IPSHX MSTSX ID MLGF KNF LICY CIRAX SEIC
 0.48 
 31.08 
Innovator
 0.00 
 11.05 
ABIVAX
 0.27 
 14.63 
Pinnacle
 0.08 
 11.87 
Morningstar
 1.75 
 0.56 
SPACE
 0.04 
 22.77 
Malaga
 1.75 
 102.75 
Knife
 0.93 
 2.17 
LiCycle
 0.16 
 72.99 
Capital
 1.07 
 82.44 
SEI
Market Volatility
(90 Days Market Risk)
Very steady
Very steady
Very steady
Very steady
Very risky
Very steady
Very steady
Dangerous
Very steady
Very steady
Market Performance
(90 Days Performance)
Very Weak
Very Weak
Good
Modest
Good
Modest
Good
OK
Weak
Solid
Odds of Financial Distress
(Probability Of Bankruptcy)
Low
Above Average
Low
Low
Average
Low
Low
Quite High
Low
Low
Current Valuation
(Equity Enterprise Value)
Fairly Valued
Fairly Valued
Fairly Valued
Fairly Valued
Over Valued
Fairly Valued
Over Valued
Under Valued
Fairly Valued
Over Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Strong Buy
Buy
Not Available
Buy
Trade Advice
(90 Days Macroaxis Advice)
Strong Hold
Strong Hold
Strong Buy
Strong Hold
Hold
Hold
Buy
Strong Sell
Strong Hold
Strong Buy
Current Ratio
N/A
2.03
N/A
N/A
N/A
N/A
N/A
17.25
N/A
4.43
Net Asset
66.27 M
110.36 M
32.77 M
116.1 M
N/A
N/A
2.6 B
886 M
104.49 B
2.52 B
EBITDA
N/A
(42.25 M)
N/A
N/A
N/A
N/A
434.42 M
(150.9 M)
N/A
424.52 M
Operating Margin
N/A
4.66
N/A
N/A
N/A
0.7
0.19
-3.0
N/A
0.27
Five Year Return
N/A
N/A
9.92
8.6
N/A
3.97
N/A
N/A
6.68
1.18
One Year Return
7.0
N/A
25.91
19.87
N/A
N/A
N/A
N/A
18.47
N/A
Beta
0.59
1.26
N/A
N/A
N/A
0.55
N/A
1.51
N/A
0.97
Number Of Employees
N/A
24
1
1
N/A
75
4.39 K
384
1
5.06 K
Three Year Return
5.1
N/A
4.1
7.0
N/A
N/A
N/A
N/A
5.32
N/A
Cash Flow From Operations
N/A
(45.66 M)
N/A
N/A
N/A
21.51 M
335.73 M
(99.8 M)
N/A
447.03 M
Total Debt
N/A
53.45 M
N/A
N/A
N/A
168.92 M
726.37 M
509.6 M
N/A
25.35 M
Bond Positions Weight
N/A
N/A
N/A
22.72
N/A
N/A
N/A
N/A
0.8
N/A
Holdings Turnover
N/A
N/A
N/A
269.0
N/A
N/A
N/A
N/A
N/A
N/A
Return On Asset
N/A
-0.44
N/A
N/A
N/A
0.0141
0.0726
-0.0933
N/A
0.13
Current Liabilities
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
224.48 M
Debt To Equity
N/A
8.03
N/A
N/A
N/A
N/A
N/A
0.65
N/A
0.015
Short Ratio
N/A
N/A
N/A
N/A
N/A
N/A
3.33
0.69
N/A
2.08
Shares Owned By Institutions
N/A
57.27
N/A
N/A
N/A
1.21
83.95
10.87
N/A
73.08
Market Capitalization
N/A
165.36 M
N/A
50.36 M
947.97 K
41.82 M
5.92 B
49.92 M
N/A
10.63 B
Price To Earning
N/A
-7.88
N/A
N/A
N/A
10.05
N/A
N/A
18.22
19.7
Price To Sales
N/A
20.65
N/A
N/A
N/A
0.92
2.05
1.82
1.86
5.18
Net Income
N/A
(41.36 M)
N/A
N/A
N/A
19.6 M
182.87 M
(138 M)
N/A
462.26 M
Shares Owned By Insiders
N/A
4.67
N/A
N/A
N/A
N/A
0.62
23.28
N/A
23.9
Revenue
N/A
37 K
N/A
N/A
N/A
40.31 M
2.83 B
18.3 M
N/A
1.92 B
Year To Date Return
N/A
N/A
19.22
13.69
N/A
N/A
N/A
N/A
12.42
N/A
Working Capital
N/A
N/A
N/A
N/A
N/A
N/A
566.27 M
(7.7 M)
N/A
1.13 B
Profit Margin
N/A
N/A
N/A
N/A
N/A
0.49
0.0689
N/A
N/A
0.27
Current Valuation
N/A
165.28 M
N/A
N/A
N/A
347.35 M
6.38 B
453.52 M
N/A
9.62 B
Price To Book
N/A
27.57
N/A
N/A
N/A
N/A
4.09
0.17
2.47
4.47
Retained Earnings
N/A
N/A
N/A
N/A
N/A
20.03 M
665.87 M
(294.7 M)
N/A
762.59 M
Current Asset
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
1 B
Equity Positions Weight
217.24
N/A
97.04
61.63
N/A
N/A
N/A
N/A
71.56
N/A
Cash Position Weight
N/A
N/A
2.96
14.28
N/A
N/A
N/A
N/A
4.87
N/A
Shares Outstanding
N/A
22.3 M
N/A
N/A
N/A
N/A
56.61 M
23.22 M
N/A
128.91 M
Annual Yield
N/A
N/A
N/A
0.021
N/A
0.0433
N/A
N/A
0.031
0.0112
Return On Equity
N/A
-12.86
N/A
N/A
N/A
0.12
0.15
-0.43
N/A
0.25
Z Score
N/A
1.8
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Book Value Per Share
N/A
0.36
N/A
N/A
N/A
19.82
25.59
12.73
N/A
18.29
Number Of Shares Shorted
N/A
N/A
N/A
N/A
N/A
N/A
1.3 M
1.38 M
N/A
1.56 M
Minimum Initial Investment
N/A
N/A
1000 K
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Asset
66.27 M
110.36 M
15.57 M
215.11 M
N/A
341.97 M
2.6 B
886 M
108.6 B
2.52 B
Last Dividend Paid
N/A
N/A
0.1
N/A
N/A
0.95
N/A
N/A
0.39
0.92
Target Price
N/A
N/A
N/A
N/A
N/A
N/A
112.57
2.63
N/A
78.8
Price To Earnings To Growth
N/A
N/A
N/A
N/A
N/A
N/A
0.92
N/A
N/A
1.26
Earnings Per Share
N/A
-2.59
N/A
N/A
N/A
2.42
3.51
-5.58
N/A
4.15
Ten Year Return
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
6.6
N/A
Cash And Equivalents
N/A
26.57 M
N/A
N/A
N/A
16.65 M
10.09 M
649.03 M
N/A
791.44 M
Cash Per Share
N/A
1.58
N/A
N/A
N/A
2.05
N/A
3.7
N/A
5.87
Gross Profit
N/A
(45.52 M)
N/A
N/A
N/A
40.31 M
N/A
(3.2 M)
N/A
1.58 B
Day Typical Price
31.04
11.05
14.63
11.87
0.56
22.78
103.55
2.18
72.99
82.39
Accumulation Distribution
43.59
N/A
N/A
N/A
69.05
0.0013
8004.99
14044.96
N/A
20313.96
Market Facilitation Index
0.0
N/A
N/A
N/A
0.0
0.03
0.0
N/A
N/A
0.0
Daily Balance Of Power
1.153846
0.0
(9,223,372,036,855)
(9,223,372,036,855)
(0.50)
0.3333
(0.55)
0.2857
9.2 T
0.6641
Period Momentum Indicator
0.15
N/A
(0.04)
(0.01)
(0.01)
0.01
(1.83)
0.02
0.12
0.87
Rate Of Daily Change
1.0
1.0
1.0
1.0
0.98
1.0
0.98
1.01
1.0
1.01
Day Median Price
31.02
11.05
14.63
11.87
0.56
22.79
103.96
2.19
72.99
82.37
Price Action Indicator
0.14
N/A
(0.02)
(0.01)
(0.01)
(0.01)
(2.12)
(0.01)
0.06
0.51
Coefficient Of Variation
(770.80)
N/A
521.81
1342.2
724.66
1246.9
505.27
1228.99
4357.69
374.17
Mean Deviation
0.4485
N/A
0.5474
0.4908
3.77
0.3742
1.55
6.73
0.3367
0.8101
Jensen Alpha
(0.12)
N/A
0.03
(0.04)
0.5298
0.0231
0.2103
0.6709
(0.05)
0.2054
Total Risk Alpha
(0.18)
N/A
0.0158
(0.06)
(0.10)
(0.05)
0.0826
(0.74)
(0.07)
0.1198
Sortino Ratio
N/A
N/A
0.0201
(0.13)
0.0984
(0.14)
0.1327
0.0886
(0.26)
0.1913
Downside Variance
N/A
N/A
0.4977
0.4354
28.2
0.3829
5.92
54.66
0.2097
0.942
Standard Deviation
0.5796
N/A
0.7547
0.6349
4.73
0.5762
2.29
9.65
0.4195
1.18
Kurtosis
0.1841
N/A
3.76
(0.03)
0.4732
1.66
5.99
4.58
(0.13)
5.03
Potential Upside
0.596
N/A
1.13
1.21
7.69
1.11
2.77
14.15
0.6553
1.57
Treynor Ratio
(0.27)
N/A
0.1549
0.06
0.684
0.3331
0.2291
0.8951
(0.0009)
0.3661
Maximum Drawdown
2.77
N/A
3.97
2.8
20.54
3.32
12.78
55.51
1.81
7.23
Variance
0.336
N/A
0.5695
0.4031
22.39
0.332
5.25
93.11
0.176
1.4
Market Risk Adjusted Performance
(0.26)
N/A
0.1649
0.07
0.694
0.3431
0.2391
0.9051
0.0091
0.3761
Risk Adjusted Performance
(0.10)
N/A
0.1464
0.0549
0.1139
0.058
0.158
0.0714
0.0093
0.2078
Skewness
(0.14)
N/A
0.223
0.0725
(0.35)
0.2685
0.0527
1.64
(0.41)
1.32
Semi Deviation
N/A
N/A
0.4498
0.5156
4.01
0.3373
1.9
6.69
0.4316
0.5731
Information Ratio
(0.35)
N/A
0.0188
(0.13)
0.1104
(0.15)
0.141
0.0679
(0.29)
0.157
Value At Risk
(1.13)
N/A
(0.98)
(1.02)
(6.67)
(0.65)
(2.46)
(10.47)
(0.82)
(1.56)
Expected Short fall
N/A
N/A
(0.68)
(0.61)
(5.10)
(0.73)
(1.62)
(8.44)
(0.34)
(0.95)
Downside Deviation
N/A
N/A
0.7055
0.6599
5.31
0.6188
2.43
7.39
0.458
0.9706
Semi Variance
N/A
N/A
0.2023
0.2658
16.1
0.1138
3.62
44.74
0.1863
0.3285

Innovator MSCI Competition Performance Charts

Five steps to successful analysis of Innovator MSCI Competition

Innovator MSCI's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Innovator MSCI EAFE in relation to its competition. Innovator MSCI's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Innovator MSCI in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Innovator MSCI's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Innovator MSCI EAFE, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Innovator MSCI position

In addition to having Innovator MSCI in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Marijuana Thematic Idea Now

Marijuana
Marijuana Theme
Small and mid-cap equities that are involved in production and delivery of Marijuana products. This theme is designed for investors that are willing to accept higher levels of market risk inherited by Marijuana production in the United States. The Marijuana theme has 49 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Marijuana Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Innovator MSCI EAFE is a strong investment it is important to analyze Innovator MSCI's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Innovator MSCI's future performance. For an informed investment choice regarding Innovator Etf, refer to the following important reports:
How To Invest In Innovator
Details
ETF Directory
View
Largest Strategy ETFs Companies
View
Largest Developed Markets Basket ETFs Companies
View
Check out Innovator MSCI Correlation with its peers.
You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
The market value of Innovator MSCI EAFE is measured differently than its book value, which is the value of Innovator that is recorded on the company's balance sheet. Investors also form their own opinion of Innovator MSCI's value that differs from its market value or its book value, called intrinsic value, which is Innovator MSCI's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Innovator MSCI's market value can be influenced by many factors that don't directly affect Innovator MSCI's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Technical
Analysis
Details
Please note, there is a significant difference between Innovator MSCI's value and its price as these two are different measures arrived at by different means. Investors typically determine if Innovator MSCI is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Innovator MSCI's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY